These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

798 related articles for article (PubMed ID: 33725908)

  • 1. Statin/ezetimibe combination therapy vs statin monotherapy for carotid atherosclerotic plaque inflammation.
    Oh M; Kim H; Shin EW; Sung C; Kim DH; Moon DH; Lee JS; Lee PH; Lee SW; Lee CW
    Medicine (Baltimore); 2021 Mar; 100(10):e25114. PubMed ID: 33725908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of ezetimibe/simvastatin 10/10 mg versus Rosuvastatin 10 mg on carotid atherosclerotic plaque inflammation.
    Oh M; Kim H; Shin EW; Sung C; Kim DH; Moon DH; Lee CW
    BMC Cardiovasc Disord; 2019 Aug; 19(1):201. PubMed ID: 31426749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of High-Dose Rosuvastatin Versus Low-Dose Rosuvastatin Plus Ezetimibe on Carotid Atherosclerotic Plaque Inflammation in Patients with Acute Coronary Syndrome.
    Oh M; Kim H; Shin EW; Sung C; Kim DH; Moon DH; Kim N; Eo JS; Kim JW; Lee CW
    J Cardiovasc Transl Res; 2020 Dec; 13(6):900-907. PubMed ID: 32367340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of fimasartan and amlodipine therapy on carotid atherosclerotic plaque inflammation.
    Oh M; Lee CW; Ahn JM; Park DW; Kang SJ; Lee SW; Kim YH; Moon DH; Park SW; Park SJ
    Clin Cardiol; 2019 Feb; 42(2):241-246. PubMed ID: 30537083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxyglucose-positron emission tomography/computed tomography feasibility study.
    Tawakol A; Fayad ZA; Mogg R; Alon A; Klimas MT; Dansky H; Subramanian SS; Abdelbaky A; Rudd JH; Farkouh ME; Nunes IO; Beals CR; Shankar SS
    J Am Coll Cardiol; 2013 Sep; 62(10):909-17. PubMed ID: 23727083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similar Impact of Clopidogrel or Ticagrelor on Carotid Atherosclerotic Plaque Inflammation.
    Oh M; Lee CW; Lee HS; Chang M; Ahn JM; Park DW; Kang SJ; Lee SW; Kim YH; Moon DH; Park SW; Park SJ
    Clin Cardiol; 2016 Nov; 39(11):646-652. PubMed ID: 27459273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of moderate-intensity statin therapy on plaque inflammation in patients with acute coronary syndrome: A prospective interventional study evaluated by 18F-FDG PET/CT of the carotid artery.
    Kim CJ; Han EJ; Chu EH; Hwang BH; Kim JJ; Seung KB; Kim SH; O JH; Chang K
    Cardiol J; 2020; 27(6):762-771. PubMed ID: 30009378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-inflammatory effect of statin is continuously working throughout use: a prospective three time point
    Kang MK; Kim CJ; Choo EH; Han EJ; Hwang BH; Kim JJ; Kim SH; O JH; Chang K
    Int J Cardiovasc Imaging; 2019 Sep; 35(9):1745-1753. PubMed ID: 31312997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of serum inflammatory biomarkers with plaque inflammation assessed by FDG PET/CT: the dal-PLAQUE study.
    Duivenvoorden R; Mani V; Woodward M; Kallend D; Suchankova G; Fuster V; Rudd JHF; Tawakol A; Farkouh ME; Fayad ZA
    JACC Cardiovasc Imaging; 2013 Oct; 6(10):1087-1094. PubMed ID: 24135322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin treatment and carotid plaque composition: a review of clinical studies.
    Puato M; Zambon A; Faggin E; Rattazzi M; Pauletto P
    Curr Vasc Pharmacol; 2014 May; 12(3):518-26. PubMed ID: 23092412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effect of ezetimibe addition on coronary atheroma regression in patients with prior statin therapy: Subanalysis of PRECISE-IVUS trial.
    Tsujita K; Yamanaga K; Komura N; Sakamoto K; Sugiyama S; Sumida H; Shimomura H; Yamashita T; Oka H; Nakao K; Nakamura S; Ishihara M; Matsui K; Sakaino N; Nakamura N; Yamamoto N; Koide S; Matsumura T; Fujimoto K; Tsunoda R; Morikami Y; Matsuyama K; Oshima S; Kaikita K; Hokimoto S; Ogawa H;
    Eur J Prev Cardiol; 2016 Sep; 23(14):1524-8. PubMed ID: 27296705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early Effects of Intensive Lipid-Lowering Treatment on Plaque Characteristics Assessed by Virtual Histology Intravascular Ultrasound.
    Lee JH; Shin DH; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Yonsei Med J; 2016 Sep; 57(5):1087-94. PubMed ID: 27401638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of statin-ezetimibe combination therapy versus statin monotherapy on coronary plaque regression in patients with acute coronary syndrome: a meta-analysis.
    Pintaningrum Y; Aditya Putra Pramana KA
    J Pak Med Assoc; 2024 Jun; 74(6 (Supple-6)):S23-S27. PubMed ID: 39018135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy.
    Foody JM; Toth PP; Tomassini JE; Sajjan S; Ramey DR; Neff D; Tershakovec AM; Hu H; Tunceli K
    Vasc Health Risk Manag; 2013; 9():719-27. PubMed ID: 24265554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pooled analyses of effects on C-reactive protein and low density lipoprotein cholesterol in placebo-controlled trials of ezetimibe monotherapy or ezetimibe added to baseline statin therapy.
    Pearson TA; Ballantyne CM; Veltri E; Shah A; Bird S; Lin J; Rosenberg E; Tershakovec AM
    Am J Cardiol; 2009 Feb; 103(3):369-74. PubMed ID: 19166691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Ezetimibe on Stabilization and Regression of Intracoronary Plaque　- The ZIPANGU Study.
    Ueda Y; Hiro T; Hirayama A; Komatsu S; Matsuoka H; Takayama T; Ishihara M; Hayashi T; Saito S; Kodama K;
    Circ J; 2017 Oct; 81(11):1611-1619. PubMed ID: 28592751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Switching From High-Efficacy Lipid-Lowering Therapies to Generic Simvastatin on LDL-C Levels and LDL-C Goal Attainment Among High-Risk Primary and Secondary Prevention Populations in the United Kingdom.
    Cao X; Ejzykowicz F; Ramey DR; Sajjan S; Ambegaonkar BM; Mavros P; Tunceli K
    Clin Ther; 2015 Apr; 37(4):804-15. PubMed ID: 25626487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of BMS-582949, a P38 mitogen-activated protein kinase (P38 MAPK) inhibitor on arterial inflammation: a multicenter FDG-PET trial.
    Emami H; Vucic E; Subramanian S; Abdelbaky A; Fayad ZA; Du S; Roth E; Ballantyne CM; Mohler ER; Farkouh ME; Kim J; Farmer M; Li L; Ehlgen A; Langenickel TH; Velasquez L; Hayes W; Tawakol A
    Atherosclerosis; 2015 Jun; 240(2):490-6. PubMed ID: 25913664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic practice patterns related to statin potency and ezetimibe/simvastatin combination therapies in lowering LDL-C in patients with high-risk cardiovascular disease.
    Toth PP; Foody JM; Tomassini JE; Sajjan SG; Ramey DR; Neff DR; Tershakovec AM; Hu XH; Tunceli K
    J Clin Lipidol; 2014; 8(1):107-16. PubMed ID: 24528691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plaque REgression with Cholesterol absorption Inhibitor or Synthesis inhibitor Evaluated by IntraVascular UltraSound (PRECISE-IVUS Trial): Study protocol for a randomized controlled trial.
    Tsujita K; Sugiyama S; Sumida H; Shimomura H; Yamashita T; Yamanaga K; Komura N; Sakamoto K; Ono T; Oka H; Nakao K; Nakamura S; Ishihara M; Matsui K; Sakaino N; Nakamura N; Yamamoto N; Koide S; Matsumura T; Fujimoto K; Tsunoda R; Morikami Y; Matsuyama K; Oshima S; Kaikita K; Hokimoto S; Ogawa H;
    J Cardiol; 2015 Oct; 66(4):353-8. PubMed ID: 25577723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.